Publicacions en què col·labora amb Álvaro Díaz Martínez (13)

2021

  1. Autoradiographic Visualization of G Protein-Coupled Receptors in Brain

    Neuromethods (Humana Press Inc.), pp. 161-174

2020

  1. β-Catenin Role in the Vulnerability/Resilience to Stress-Related Disorders Is Associated to Changes in the Serotonergic System

    Molecular Neurobiology, Vol. 57, Núm. 3, pp. 1704-1715

2019

  1. Targeting β-Catenin in GLAST-Expressing Cells: Impact on Anxiety and Depression-Related Behavior and Hippocampal Proliferation

    Molecular Neurobiology, Vol. 56, Núm. 1, pp. 553-566

2017

  1. Enhanced Stress Response in 5-HT1AR Overexpressing Mice: Altered HPA Function and Hippocampal Long-Term Potentiation

    ACS Chemical Neuroscience, Vol. 8, Núm. 11, pp. 2393-2401

2016

  1. Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: Role of 5-HT1A receptors

    Neuropharmacology, Vol. 103, pp. 16-26

  2. The absence of 5-HT4 receptors modulates depression- and anxiety-like responses and influences the response of fluoxetine in olfactory bulbectomised mice: Adaptive changes in hippocampal neuroplasticity markers and 5-HT1A autoreceptor

    Neuropharmacology, Vol. 111, pp. 47-58

2014

  1. Serotonin 5-HT4 receptors: A new strategy for developing fast acting antidepressants?

    Current Pharmaceutical Design, Vol. 20, Núm. 23, pp. 3751-3762

  2. Signaling pathways involved in antidepressant-induced cell proliferation and synaptic plasticity

    Current Pharmaceutical Design, Vol. 20, Núm. 23, pp. 3776-3794

2013

  1. Neural plasticity and proliferation in the generation of antidepressant effects: Hippocampal implication

    Neural Plasticity, Vol. 2013

  2. Region-specific regulation of 5-HT1B receptors in the rat brain by chronic venlafaxine treatment

    Psychopharmacology, Vol. 229, Núm. 1, pp. 177-185

2012

  1. Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3 and 7 days) administration of the 5-HT 4 receptor agonist RS67333

    International Journal of Neuropsychopharmacology, Vol. 15, Núm. 5, pp. 631-643

2011

  1. New strategies in the development of antidepressants: Towards the modulation of neuroplasticity pathways

    Current Pharmaceutical Design, Vol. 17, Núm. 5, pp. 521-533

2010

  1. Long-term fluoxetine treatment modulates cannabinoid type 1 receptor-mediated inhibition of adenylyl cyclase in the rat prefrontal cortex through 5-hydroxytryptamine1A receptor-dependent mechanisms

    Molecular Pharmacology, Vol. 77, Núm. 3, pp. 424-434